Tag pharmacokinetics [82 articles] Export

Recent papers classified by the tag pharmacokinetics.

	Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling. [My Copy] Journal of pharmacokinetics and pharmacodynamics, Vol. 34, No. 3. (June 2007), pp. 333-354. by Anasuya Hazra, Debra C. DuBois, Richard R. Almon, William J. Jusko posted to dynamic_model pharmacokinetics glucocorticoid_receptor by schwartzjmc on 2009-11-03 10:03:32 as
	$My PDF briley-saebo_08_fractionated.pdf$ Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis. [My Copy] Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine, Vol. 59, No. 4. (April 2008), pp. 721-730. by Karen C. Briley-Saebo, Venkatesh Mani, Fabien Hyafil, Jean-Christophe C. Cornily, Zahi A. Fayad posted to pharmacokinetics by kaliavinash7 on 2009-09-14 05:52:56 as
	A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients. [My Copy] British journal of clinical pharmacology, Vol. 48, No. 5. (November 1999), pp. 669-677. by M. Hassan, U. S. Svensson, P. Ljungman, et al.B. Björkstrand, H. Olsson, M. Bielenstein, M. Abdel-Rehim, C. Nilsson, M. Johansson, M. O. Karlsson posted to variability pharmacokinetics interindividual cyclophosphamide by songpku on 2009-08-27 20:18:25 as
	Pharmacokinetics of high-dose oseltamivir in healthy volunteers. [My Copy] Antimicrobial agents and chemotherapy, Vol. 53, No. 3. (March 2009), pp. 945-952. by Y. Wattanagoon, K. Stepniewska, N. Lindegårdh, et al.S. Pukrittayakamee, U. Silachamroon, W. Piyaphanee, T. Singtoroj, W. Hanpithakpong, G. Davies, J. Tarning, W. Pongtavornpinyo, C. Fukuda, P. Singhasivanon, N. P. Day, N. J. White posted to pharmacokinetics oseltamivir influenza h1n1 by virolog on 2009-08-24 23:36:27 as
	Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging [My Copy] Magnetic Resonance in Medicine, Vol. 60, No. 6. (2008), pp. 1353-1361. by Anne M. Neubauer, Hoon Sim, Patrick M. Winter, et al.Shelton D. Caruthers, Todd A. Williams, J. David Robertson, David Sept, Gregory M. Lanza, Samuel A. Wickline posted to alpha-nu-beta3-integrin atherosclerosis ccne-grant mri pharmacokinetics sccne by ml115 on 2009-07-27 16:34:36 as along with 2 people and 1 group paulschlesinger sobolevnrm baker-group
	Literature mining on pharmacokinetics numerical data: A feasibility study [My Copy] Journal of Biomedical Informatics, Vol. 42, No. 4. (1 August 2009), pp. 726-735. by Zhiping Wang, Seongho Kim, Sara K. Quinney, et al.Yingying Guo, Stephen D. Hall, Luis M. Rocha, Lang Li posted to clearance data entity extraction information linear midazolam mining mixed model pharmacokinetics recognition text by zimbo1 on 2009-07-27 14:30:11 as
	Evaluation of Pharmacokinetics of Bioreducible Gene Delivery Vectors by Real-time PCR [My Copy] Pharmaceutical Research, Vol. 26, No. 7. (1 July 2009), pp. 1581-1589. by Qing-Hui Zhou, Chao Wu, Devika Manickam, David Oupický posted to tumor targeting-peptide real-time-pcr polymer-nanoparticle pharmacokinetics in-vivo gene-delivery by ml115 on 2009-07-24 21:08:56 as
	Pharmacokinetics of Plasma Efavirenz and CYP2B6 Polymorphism in Southern Chinese. [My Copy] Therapeutic drug monitoring (11 June 2009) by Kin W. To, Shui T. Liu, Siu W. Cheung, D. Pui Chan, R. Chiu Chan, Shui S. Lee posted to southern pharmacokinetics nnn cyp2b6 china by zzangleehyok to the group Asian Pharmacogenetics Library on 2009-07-14 09:43:43 as
	Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 27. (7 July 2009), pp. 11394-11399. by Thomas Schluep, Jungyeon Hwang, Isabel J. Hildebrandt, et al.Johannes Czernin, Chung H. Choi, Christopher A. Alabi, Brendan C. Mack, Mark E. Davis posted to biodistribution in-vivo pet-imaging pharmacokinetics polymer-nanoparticle radioisotope tumor zeta-potential by ml115 on 2009-07-08 20:55:35 as along with 1 person sobolevnrm
	The Role of the Size and Number of Polyethylene Glycol Chains in the Biodistribution and Tumor Localization of Triazine Dendrimers [My Copy] Molecular Pharmaceutics, Vol. 5, No. 4. (1 August 2008), pp. 540-547. by Jongdoo Lim, Yi Guo, Cynthia L. Rostollan, et al.Jennifer Stanfield, Jer-Tsong Hsieh, Xiankai Sun, Eric E. Simanek posted to biodistribution dendrimer in-vivo pharmacokinetics tumor by ml115 on 2009-06-18 21:20:11 as
	Fc Glycans Terminated with N-Acetylglucosamine Residues Increase Antibody Resistance to Papain [My Copy] Biotechnology Progress, Vol. 23, No. 4. (2007), pp. 964-971. by Shantha T. Raju, Bernard Scallon posted to antibody n-glycan pharmacokinetics proteolysis by cnishida on 2009-06-12 19:13:37 as
	Bridging the gap: ageing, pharmacokinetics and pharmacodynamics [My Copy] Journal of Pharmacy and Pharmacology, Vol. 57, No. 6. (June 2005), pp. 671-680. by Dominick G. Burton, Marcus C. Allen, Joseph L. Bird, Richard G. Faragher posted to ageing pharmacodynamics pharmacokinetics senescence by cozmic on 2009-05-18 17:32:00 as
	Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus [My Copy] J Clin Pharmacol, Vol. 48, No. 12. (1 December 2008), pp. 1389-1399. by Prajakti A. Kothare, Helle Linnebjerg, Yoshitaka Isaka, et al.Kazunori Uenaka, Ayuko Yamamura, Kwee P. Yeo, de La, Choo H. Teng, Kenneth Mace, Mark Fineman, Hirofumi Shigeta, Yukikuni Sakata, Shin Irie posted to adverse-effects adverse-events clinical-trials diabetes dynamics effects health-states kinetics pharmaceutical pharmacodynamics pharmacokinetics pharmacology safety tolerability by Scis0000002 on 2009-05-07 10:10:14 as
	Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal study [My Copy] Nuclear Medicine and Biology, Vol. 23, No. 7. (October 1996), pp. 897-906. by G. Brix posted to fluorouracil mri pet pharmacokinetics by YvesDeDeene on 2009-04-05 10:52:02 as
	Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging [My Copy] Magnetic Resonance Imaging, Vol. 17, No. 1. (February 1999), pp. 151-155. by G. Brix posted to fluorine fluorouracil mri pharmacokinetics by YvesDeDeene on 2009-04-05 10:44:18 as
	A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS [My Copy] Br J Radiol, Vol. 72, No. 858. (1 June 1999), pp. 584-589. by H. Ikehira, F. Girard, T. Obata, et al.H. Ito, H. Yoshitomi, M. Miyazaki, N. Nakajima, H. Kamei, Y. Kanazawa, H. Takano, H. Ito, S. Tanada, Y. Sasaki posted to fluorine mri mrs pharmacokinetics by YvesDeDeene on 2009-04-05 10:41:16 as
	Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). [My Copy] Journal of analytical toxicology, Vol. 30, No. 8. (October 2006), pp. 603-610. by T. L. Martin, K. L. Woodall, B. A. McLellan posted to fentanyl opioid pharmacokinetics by richardh on 2009-03-22 10:36:52 as
	Interpretation of Opioid Levels: Comparison of Levels During Chronic Pain Therapy to Levels from Forensic Autopsies[ast] [My Copy] Clin Pharmacol Ther, Vol. 77, No. 4. (April 2005), pp. 324-334. by Beth F. Jung, Marcus M. Reidenberg posted to fentanyl opioid pharmacokinetics by richardh on 2009-03-22 10:34:52 as
	Fentanyl Concentrations in 23 Postmortem Cases from the Hennepin County Medical Examiners Office [My Copy] Journal of Forensic Sciences, Vol. 52, No. 4. (July 2007), pp. 978-981. by Thompson, G. Jonathan, Baker, et al.M. Andrew, Bracey, H. Anne, Seningen, Justin, Kloss, S. Julie, Strobl, A. Quinn, Apple, S. Fred posted to fentanyl pharmacokinetics postmortem by richardh on 2009-03-22 10:10:30 as
	The therapeutic monitoring of antimicrobial agents. [My Copy] British journal of clinical pharmacology, Vol. 52 Suppl 1 (2001) by E. J. Begg, M. L. Barclay, C. M. Kirkpatrick posted to pharmacokinetics tdm by lewista on 2008-11-25 15:01:15 as
	Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. [My Copy] Pharmaceutical research, Vol. 22, No. 9. (September 2005), pp. 1425-1431. by J. Smolec, B. DeSilva, W. Smith, et al.R. Weiner, M. Kelly, B. Lee, M. Khan, R. Tacey, H. Hill, A. Celniker, V. Shah, R. Bowsher, A. Mire-Sluis, J. W. Findlay, M. Saltarelli, V. Quarmby, D. Lansky, R. Dillard, M. Ullmann, S. Keller, H. T. Karnes posted to pharmacokinetics by roslyn on 2008-11-25 03:35:37 as
	High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. [My Copy] Archives of internal medicine, Vol. 166, No. 19. (23 October 2006), pp. 2138-2144. by L. K. Hidayat, D. I. Hsu, R. Quist, K. A. Shriner, A. Wong-Beringer posted to glycopeptide pharmacokinetics by lewista on 2008-11-20 15:34:55 as
	The comparative efficacy and safety of teicoplanin and vancomycin. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 38, No. 6. (December 1996), pp. 1113-1114. by J. Cobo, J. Fortún posted to glycopeptide pharmacokinetics by lewista on 2008-11-20 15:29:47 as
	The comparative efficacy and safety of teicoplanin and vancomycin. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 37, No. 2. (February 1996), pp. 209-222. by M. J. Wood posted to glycopeptide pharmacokinetics by lewista on 2008-11-20 15:20:24 as
	Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 51, No. 4. (April 2003), pp. 971-975. by F. Pea, L. Brollo, P. Viale, F. Pavan, M. Furlanut posted to glycopeptide pharmacokinetics by lewista on 2008-11-20 15:13:19 as
	Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. [My Copy] The Journal of antimicrobial chemotherapy, Vol. 55, No. 3. (March 2005), pp. 333-340. by T. Whitehouse, J. A. Cepeda, R. Shulman, et al.L. Aarons, R. Nalda-Molina, C. Tobin, A. MacGowan, S. Shaw, C. Kibbler, M. Singer, A. P. Wilson posted to glycopeptide pharmacokinetics by lewista on 2008-11-20 15:05:41 as
	Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. [My Copy] Rheumatology (Oxford, England), Vol. 46, No. 12. (December 2007), pp. 1828-1834. by M. Svenson, P. Geborek, T. Saxne, K. Bendtzen posted to immunogenicity pharmacokinetics by roslyn on 2008-11-18 22:42:41 as along with 1 person sahrazanetti
	Plasma levels and pharmacokinetics of ethynyl estrogens in various populations I. Ethynylestradiol [My Copy] Contraception, Vol. 21, No. 1. (January 1980), pp. 1-16. by J. Goldzieher posted to comparisons estrogen pharmacokinetics population by Zephyrus to the group Estrogen Nation on 2008-11-17 02:15:08 as
	Species similarities and differences in pharmacokinetics. [My Copy] Drug metabolism and disposition: the biological fate of chemicals, Vol. 23, No. 10. (October 1995), pp. 1008-1021. by J. H. Lin posted to major_ass pharmacokinetics species by roslyn on 2008-11-08 02:26:12 as along with 1 person medhakhanna
	Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin. [My Copy] Drug metabolism and disposition: the biological fate of chemicals, Vol. 35, No. 9. (September 2007), pp. 1672-1678. by S. Woo, W. J. Jusko posted to allometric_scaling biologics pharmacokinetics by sahrazanetti on 2008-11-07 07:59:57 as
	Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in first relapse. [My Copy] Journal of clinical pharmacology, Vol. 41, No. 11. (November 2001), pp. 1206-1214. by J. A. Dowell, J. Korth-Bradley, H. Liu, S. P. King, M. S. Berger posted to antibody major_ass pharmacokinetics by roslyn on 2008-11-07 01:32:53 as
	Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia. [My Copy] Journal of clinical pharmacology, Vol. 44, No. 8. (August 2004), pp. 873-880. by M. Buckwalter, J. A. Dowell, J. Korth-Bradley, B. Gorovits, P. R. Mayer posted to antibody major_ass pharmacokinetics by roslyn on 2008-11-07 01:32:23 as
	Role of pharmacokinetics and metabolism in drug discovery and development. [My Copy] Pharmacological reviews, Vol. 49, No. 4. (December 1997), pp. 403-449. by J. H. Lin, A. Y. Lu posted to pharmacokinetics by roslyn on 2008-11-06 23:43:48 as along with 1 person sahrazanetti
	Drug interaction studies of therapeutic proteins or monoclonal antibodies. [My Copy] Journal of clinical pharmacology, Vol. 47, No. 12. (December 2007), pp. 1540-1554. by I. Mahmood, M. D. Green posted to pharmacokinetics by roslyn on 2008-11-06 23:14:23 as along with 1 person sahrazanetti
	Population pharmacokinetics of infliximab in patients with ankylosing spondylitis. [My Copy] Journal of clinical pharmacology, Vol. 48, No. 6. (June 2008), pp. 681-695. by Z. Xu, K. Seitz, A. Fasanmade, et al.J. Ford, P. Williamson, W. Xu, H. M. Davis, H. Zhou posted to pharmacokinetics by roslyn on 2008-11-06 23:13:20 as
	Biodistribution and Pharmacokinetic Analysis of Paclitaxel and Ceramide Administered in Multifunctional Polymer-Blend Nanoparticles in Drug Resistant Breast Cancer Model [My Copy] Mol. Pharmaceutics, Vol. 5, No. 4. (4 August 2008), pp. 516-526. by Lilian E. van Vlerken, Zhenfeng Duan, Steven R. Little, Michael V. Seiden, Mansoor M. Amiji posted to biodistribution ccne-grant ceramide multi-drug-resistance neu-ccne paclitaxel pharmacokinetics polymer-nanoparticle by ml115 on 2008-10-27 14:13:18 as
	The allometric approach for interspecies scaling of pharmacokinetic parameters [My Copy] Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, Vol. 103, No. 2. (October 1992), pp. 249-253. by W. Ritschel posted to allometric_scaling pharmacokinetics by sahrazanetti on 2008-10-19 11:44:24 as
	Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. [My Copy] The Journal of pharmacology and experimental therapeutics, Vol. 288, No. 1. (January 1999), pp. 371-378. by Y. S. Lin, C. Nguyen, J. L. Mendoza, et al.E. Escandon, D. Fei, Y. G. Meng, N. B. Modi posted to allometric_scaling antibody pharmacokinetics by sahrazanetti on 2008-10-19 10:39:05 as
	Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody. [My Copy] European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 21, No. 2-3. (February 2004), pp. 261-270. by J. Duconge, R. Castillo, T. Crombet, et al.D. Alvarez, J. Matheu, G. Vecino, K. Alonso, I. Beausoleil, C. Valenzuela, M. A. Becquer, E. Fernández-Sánchez posted to allometric_scaling antibody pharmacokinetics by sahrazanetti on 2008-10-19 10:35:42 as
	Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins. [My Copy] Expert opinion on biological therapy, Vol. 5 Suppl 1 (September 2005) by D. Ternant, G. Paintaud posted to antibody pharmacokinetics by roslyn on 2008-10-19 06:04:50 as
	Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates. [My Copy] Drug metabolism and disposition: the biological fate of chemicals, Vol. 35, No. 1. (January 2007), pp. 86-94. by A. Datta-Mannan, D. R. Witcher, Y. Tang, J. Watkins, W. Jiang, V. J. Wroblewski posted to antibody pharmacokinetics by roslyn on 2008-10-19 06:02:31 as
	Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. [My Copy] The Journal of biological chemistry, Vol. 282, No. 3. (19 January 2007), pp. 1709-1717. by A. Datta-Mannan, D. R. Witcher, Y. Tang, J. Watkins, V. J. Wroblewski posted to antibody pharmacokinetics by roslyn on 2008-10-19 05:58:59 as
	Antibody pharmacokinetics and pharmacodynamics. [My Copy] Journal of pharmaceutical sciences, Vol. 93, No. 11. (November 2004), pp. 2645-2668. by E. D. Lobo, R. J. Hansen, J. P. Balthasar posted to antibody pharmacokinetics by roslyn on 2008-10-19 05:49:18 as
	Elimination mechanisms of therapeutic monoclonal antibodies. [My Copy] Drug discovery today, Vol. 11, No. 1-2. (January 2006), pp. 81-88. by M. A. Tabrizi, C. M. Tseng, L. K. Roskos posted to antibody pharmacokinetics by roslyn on 2008-10-19 05:25:17 as
	Monoclonal Antibody Pharmacokinetics and Pharmacodynamics. [My Copy] Clinical pharmacology and therapeutics (10 September 2008) by W Wang, Eq Wang, Jp Balthasar posted to antibody pharmacokinetics by roslyn on 2008-10-19 05:23:40 as
	Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable? [My Copy] Biopharmaceutics & drug disposition, Vol. 25, No. 4. (May 2004), pp. 177-186. by J. Ducongé, E. Fernández-Sánchez, D. Alvarez posted to allometric_scaling biologics pharmacokinetics by sahrazanetti on 2008-10-16 12:00:39 as
	Physiologically based approaches towards the prediction of pharmacokinetics: in vitroin vivo extrapolation [My Copy] Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, No. 6. (December 2007), pp. 865-878. by De Buck, S. Stefan, Mackie, E. Claire posted to in_vitro in_vivo pharmacokinetics by sahrazanetti on 2008-10-12 10:39:55 as
	Prediction of human pharmacokinetics gastrointestinal absorption [My Copy] Journal of Pharmacy and Pharmacology, Vol. 59, No. 7. (July 2007), pp. 905-916. by Fagerholm, Urban posted to absorption humans pharmacokinetics by sahrazanetti on 2008-10-11 18:21:51 as
	Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. [My Copy] Current drug metabolism, Vol. 7, No. 2. (February 2006), pp. 165-182. by S. S. Singh posted to pharmacokinetics preclinical by sahrazanetti on 2008-10-11 17:59:10 as
	PK/PD Modelling and Beyond: Impact on Drug Development. [My Copy] Pharmaceutical research (23 September 2008) by Douwe D. Breimer posted to pharmacokinetics by roslyn on 2008-10-07 06:44:45 as

Note: You may cite this page as: http://www.citeulike.org/tag/pharmacokinetics

Result page: 1 2 Next

antibody	28
allometric_scaling	22
biologics	15
preclinical	13
major_ass	9
biodistribution	7
primate	6
clearance	5
glycopeptide	5
tumor	5
humans	4
in-vivo	4
mri	4
nce	4
opioid	4
pharmacodynamics	4
polymer-nanoparticle	4
ccne-grant	3
drug_development	3
fentanyl	3
pharmacology	3
review	3
species	3
addiction	2
alpha-nu-beta3-integrin	2
aromatase	2
assignment_4	2
bbb	2
buprenorphine	2
cb1954	2
cdept	2
chrono-pharmacology	2
clinical	2
cns	2
comparisons	2
dept	2
drug	2
estradiol	2
estrogen	2
estrogens	2
fluorine	2
fluorouracil	2
immunogenicity	2
in_vitro	2
in_vivo	2
laam	2
linezolid	2
ntr	2
p-glycoprotein	2
paclitaxel	2
population	2
radioisotope	2
remifentanyl	2
sccne	2
transporter	2
vdept	2
women	2
3h-paclitaxel	1
absorption	1
atherosclerosis	1
bnct	1
cancer	1
clinical-trials	1
cyp2b6	1
data	1
dynamics	1
effects	1
exemestane	1
extraction	1
gamma-camera	1
glucocorticoid_receptor	1
glucocorticoids	1
h1n1	1
half-life	1
indium	1
influenza	1
linear	1
medicine	1
microdialysis	1
mining	1
mit-mgh-ccne	1
mixed	1
modeling	1
nanoparticles	1
neu-ccne	1
nnn	1
noninvasive-detection	1
pegylation	1
pharmaceutical	1
postmortem	1
proteolysis	1
real-time-pcr	1
recognition	1
reticuloendothelial-organs	1
safety	1
southern	1
steroid	1
targeting-peptide	1
text	1
zeta-potential	1

Tag pharmacokinetics [82 articles] Export

Related Tags